The presence of cadherin and desmosomal complexes expand the realm of possibilities for modulating catenin signaling capacity in cancer cells, presenting novel therapeutic strategies for combating metastatic dissemination in colorectal cancer, and being particularly relevant for poorly-differentiated tumors. Here, CDH17 is linked to colorectal cancer.